The city of Osaka in Japan is one of the financial hubs of Asia, as well as the second-largest metropolitan area. The economic dynamics are driven primarily by Osaka Prefecture, which accounts for nearly 50% of the GDP of Japan's fourth-most-populous metropolitan area. The central region of Gohoku has a GDP per capita that's greater than that of the national average by nearly 40%. Capitalizing on its role as a center for commerce and industry, Osaka is rich in venture capital investors.
This article is part of a series where we present you the best Venture Capital firms across different cities and countries. Here you can view the ranking for Tokyo.
Top Venture capital firms in Osaka
1. Osaka University Venture Capital
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.
Total fund size: ¥22B
Osaka University Venture Capital's most notable exits include Kringle Pharma, JTEC CORPORATION Japan, and Bioworks Japan.
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan.
The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, andother names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone hydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business.
Other businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents & clinical diagnostics, photographic chemicals, and inorganic chemicals.
Total fund size: $57.8M
Takeda's most notable exits include Seagen, Ultragenyx Pharmaceutical, and Alnylam Pharmaceuticals.
3. Kintetsu Venture Partners
Kintetsu Venture Partners is a corporate venture capital of the Kintetsu Group. The firm aims to create new businesses and opening up a bright future through collaborative creation with venture companies. Kintetsu Venture Partners was founded in 2018 and based in Osaka, Japan.